Monitor for any subsequent customer adoption announcements or partnership agreements for the charging platform, as the filing contains no commercial traction. The subsidiary's technology is early-stage and unproven in the market.
Price Chart
Executive Summary
Clearmind Medicine's 51%-owned subsidiary Charging Robotics launched a next-generation automated EV-charging platform for robotaxis and autonomous fleets, using resonant inductive power transfer technology. The filing is a product launch press release with no financial data, revenue, or commercial agreements disclosed.
Key Facts
- Charging Robotics Ltd., 51%-owned subsidiary of Clearmind, launched next-gen autonomous EV-charging platform
- Platform uses resonant inductive power transfer, up to 10 kW charging power, up to 95% efficiency
- Target applications: automated parking facilities, robotaxis, and autonomous fleets
- No financial terms, revenue projections, customer agreements, or commercial partnerships disclosed
- Clearmind remains a clinical-stage biotech; the subsidiary's EV-charging business is a diversification play
Financial Impact
No financial figures provided; product launch with no disclosed revenue or contracts
Risk Factors
- No disclosed commercial agreements or revenue from the new platform
- Clearmind is a clinical-stage biotech with no approved products; the EV-charging subsidiary is a non-core diversification
- Forward-looking statements with no binding commitments or timelines
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-108644 |
| Document: ea030833702ex99-1.htm | 0001213900-26-108644 |
| Document: 0001213900-26-108644-index-headers.html | 0001213900-26-108644 |
| Document: 0001213900-26-108644-index.html | 0001213900-26-108644 |
| Document: 0001213900-26-108644.txt | 0001213900-26-108644 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 6-K | $6.00 | awaiting T+60 | — | $6.12 (−2.02%) |
Oct 13, 2026 13d ago | 6-K | $6.23 | awaiting T+60 | — | $6.12 (−1.74%) |
Oct 8, 2026 18d ago | 6-K | $6.60 | awaiting T+60 | — | $6.12 (−7.25%) |
Oct 7, 2026 19d ago | 6-K | $6.60 | awaiting T+60 | — | $6.12 (−7.25%) |
Sep 23, 2026 4w ago | 6-K | $0.8500 | awaiting T+60 | — | $6.12 (+620.16%) |
Sep 23, 2026 4w ago | Press Release | $0.8500 | awaiting T+60 | — | $6.12 (+620.16%) |
Sep 17, 2026 5w ago | Press Release | $6.86 | awaiting T+60 | — | $6.12 (−10.82%) |
Sep 14, 2026 6w ago | 6-K | $0.9440 | awaiting T+60 | — | $6.12 (+548.45%) |
Sep 8, 2026 6w ago | 6-K | $1.03 | awaiting T+60 | — | $6.12 (+494.31%) |
Sep 4, 2026 7w ago | 6-K | $1.16 | awaiting T+60 | — | $6.12 (−427.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers